ArticleJAAD international2026

Comparative ocular safety of dupilumab and oral Janus kinase inhibitors in atopic dermatitis: A real-world propensity-matched analysis.

Robert Adler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.